92 related articles for article (PubMed ID: 3114435)
1. Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.
Miser JS; Kinsella TJ; Triche TJ; Tsokos M; Jarosinski P; Forquer R; Wesley R; Magrath I
J Clin Oncol; 1987 Aug; 5(8):1191-8. PubMed ID: 3114435
[TBL] [Abstract][Full Text] [Related]
2. Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the French Society of Paediatric Oncology.
Gentet JC; Brunat-Mentigny M; Demaille MC; Pein F; Avet-Loiseau H; Berger C; De Lumley L; Pacquement H; Schmitt C; Sariban E; Pillon P; Bernard JL; Kalifa C
Eur J Cancer; 1997 Feb; 33(2):232-7. PubMed ID: 9135494
[TBL] [Abstract][Full Text] [Related]
3. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup.
Souhami RL; Craft AW; Van der Eijken JW; Nooij M; Spooner D; Bramwell VH; Wierzbicki R; Malcolm AJ; Kirkpatrick A; Uscinska BM; Van Glabbeke M; Machin D
Lancet; 1997 Sep; 350(9082):911-7. PubMed ID: 9314869
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. A Pediatric Oncology Group Phase II study.
Kung FH; Pratt CB; Vega RA; Jaffe N; Strother D; Schwenn M; Nitschke R; Homans AC; Holbrook CT; Golembe B
Cancer; 1993 Mar; 71(5):1898-903. PubMed ID: 8448755
[TBL] [Abstract][Full Text] [Related]
5. Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization.
McAloney CA; Makkawi R; Budhathoki Y; Cannon MV; Franz EM; Gross AC; Cam M; Vetter TA; Duhen R; Davies AE; Roberts RD
Cell Oncol (Dordr); 2024 Feb; 47(1):259-282. PubMed ID: 37676378
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the Impact of Chemotherapy on Ewing Sarcoma Cells through Combination with Cold Physical Plasma.
Nitsch A; Qarqash S; Römer S; Schoon J; Ekkernkamp A; Niethard M; Reichert JC; Wassilew GI; Tzvetkov MV; Haralambiev L
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240019
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and Toxicity of Interval-Compressed Chemotherapy in Asian Children and Young Adults with Sarcoma.
Huang JH; Chen SH; Liao YM; Kao YC; Ho WL; Chang H; Tsai ML; Lee HL; Kuo CC; Tseng SH; Chang CY; Hsieh KL; Lu LS; Chen YJ; Chiou JF; Hsieh TH; Liu YR; Hsu W; Li WT; Wu YC; Wu WC; Wang JL; Tsai JJ; Terashima K; Kiyotani C; Wong TT; Miser JS; Liu YL
J Pers Med; 2023 Apr; 13(4):. PubMed ID: 37109054
[TBL] [Abstract][Full Text] [Related]
8. Osteogenic Sarcoma of the Head and Neck: Is Chemotherapy Needed?
Bialick S; Campoverde L; Gallegos JAO; Barreto-Coelho P; Watson A; Arora K; Perez A; Lopez E; Venkat S; Rosenberg AE; Crawford B; Jonczak E; Trent J; Dhir A; D'Amato G
Curr Treat Options Oncol; 2023 May; 24(5):528-541. PubMed ID: 37017908
[TBL] [Abstract][Full Text] [Related]
9. Controversies and Challenges in the Management of Osteosarcoma-an Indian Perspective.
Mittal A; Pushpam D; Ganguly S; Kumar VS; Khan SA; Bakhshi S
Indian J Surg Oncol; 2022 Dec; 13(4):939-955. PubMed ID: 36687236
[TBL] [Abstract][Full Text] [Related]
10. The Role of a Multidisciplinary Team in the Diagnosis and Treatment of Bone and Soft Tissue Sarcomas: A Single-Center Experience.
Pang K; Guo X; Liu T; Wang L; Chen R; Zhang Z; Li L; He Y; Zhang H; Fan S; Tu C; Li Z
J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556299
[TBL] [Abstract][Full Text] [Related]
11. Extraosseous Ewing's sarcoma/peripheral primitive neuroectodermal tumour of the kidney: a case report and literature review.
Li J; Nie F; Li Y
BMC Urol; 2022 Nov; 22(1):197. PubMed ID: 36451163
[TBL] [Abstract][Full Text] [Related]
12. Ewing's sarcoma of the male external genitalia: a case report and review of the literature.
Rachapudi S; Srinivasan A; Gorman B; Wilhelm AB; Eyzaguirre E; Orihuela E
BMC Urol; 2022 Aug; 22(1):121. PubMed ID: 35941637
[TBL] [Abstract][Full Text] [Related]
13. Tumor lysis syndrome following ifosfamide monotherapy in metastatic osteosarcoma: a case report and review of the literature.
Luminais SN; Chen XT; Roman D; Ma B; Christ AB; Hu JS
J Med Case Rep; 2022 Jun; 16(1):252. PubMed ID: 35761364
[TBL] [Abstract][Full Text] [Related]
14. Transitioning ifosfamide chemotherapy regimens to the ambulatory setting: reviewing cost savings and safety profile.
Banh C; Valsvik K; Arredondo A; Notbohm K; Elquza E; Babiker H; Kraft A; Boiles AR; Persky D; Ortega A; McBride A
Support Care Cancer; 2022 Mar; 30(3):2755-2766. PubMed ID: 34825982
[TBL] [Abstract][Full Text] [Related]
15. Apatinib plus ifosfamide and etoposide for relapsed or refractory osteosarcoma: A retrospective study in two centres.
Xie L; Xu J; Sun X; Li X; Liu K; Liang X; Zhou Z; Zhuang H; Sun K; Wu Y; Gu J; Guo W
Oncol Lett; 2021 Jul; 22(1):552. PubMed ID: 34093773
[TBL] [Abstract][Full Text] [Related]
16. Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives.
Zöllner SK; Amatruda JF; Bauer S; Collaud S; de Álava E; DuBois SG; Hardes J; Hartmann W; Kovar H; Metzler M; Shulman DS; Streitbürger A; Timmermann B; Toretsky JA; Uhlenbruch Y; Vieth V; Grünewald TGP; Dirksen U
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33919988
[TBL] [Abstract][Full Text] [Related]
17. Secondary
Kimbara S; Imamura Y; Kiyota N; Takakura H; Matsumoto S; Koyama T; Fujishima Y; Funakoshi Y; Toyoda M; Hirose T; Kanzawa M; Kawamoto T; Hara H; Minami H
Mol Clin Oncol; 2021 Apr; 14(4):68. PubMed ID: 33680459
[TBL] [Abstract][Full Text] [Related]
18. Effect of Cisplatin Arterial Infusion (CAI) on Primary Nonmetastatic Pelvic Osteosarcoma: A Preliminary Study.
Hu X; Chen X; Li T; Liu Z; Guo X; Ouyang Z
Cancer Manag Res; 2021; 13():1491-1503. PubMed ID: 33623429
[TBL] [Abstract][Full Text] [Related]
19. High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series.
Palmerini E; Setola E; Grignani G; D'Ambrosio L; Comandone A; Righi A; Longhi A; Cesari M; Paioli A; Hakim R; Pierini M; Marchesi E; Vanel D; Pignochino Y; Donati DM; Picci P; Ferrari S
Cells; 2020 Oct; 9(11):. PubMed ID: 33142760
[No Abstract] [Full Text] [Related]
20. Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects.
Pushpam D; Garg V; Ganguly S; Biswas B
Onco Targets Ther; 2020; 13():5093-5112. PubMed ID: 32606731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
